Magromag

Nitrofurantoin, the active ingredient in Magromag, is a nitrofuran antibiotic presented as an oral tablet for systemic use. It is indicated for the treatment of uncomplicated urinary tract infections, especially cystitis, in adult patients. The agent works by inhibiting bacterial pyruvate‑ferredoxin oxidoreductase, disrupting carbohydrate metabolism and bacterial cell wall synthesis.

GNH USA supplies Magromag as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution.

Nitrofurantoin is a nitrofuran antibiotic used to treat infections of the urinary tract.

- Uncomplicated urinary tract infection: eliminates the causative bacteria, relieving symptoms and preventing progression. - Cystitis: provides bacterial eradication in bladder infection, leading to symptom resolution. - Recurrent uncomplicated urinary tract infection: used as a prophylactic agent to reduce recurrence frequency.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Loss of appetite: reduced desire to eat. - Headache: transient cranial discomfort. - Diarrhea: loose stools, usually self‑limiting.

Serious or Rare Side Effects: - Pulmonary toxicity: interstitial pneumonitis or fibrosis, may be severe. - Hepatic injury: elevated liver enzymes or hepatitis. - Hemolytic anemia: especially in patients with G6PD deficiency, leading to rapid red‑cell destruction.

Before prescribing Nitrofurantoin, consider the following precautions: - Renal function: assess creatinine clearance; avoid in severe renal impairment. - Pregnancy: use only if benefits outweigh potential risks, as safety category is unknown. - G6PD deficiency: risk of hemolysis; evaluate before initiation. - Elderly patients: monitor for pulmonary toxicity and renal function. - Drug interactions: avoid concomitant use with antacids containing magnesium or aluminum. - Store at ambient temperature: keep in original container, protect from moisture and light.

Nitrofurantoin may interact with several medicines.

Major Interactions (Avoid): - Antacids containing magnesium or aluminum: reduce nitrofurantoin absorption. - Warfarin: may increase INR and bleeding risk. - Methenamine: antagonistic effect, decreasing efficacy.

Moderate Interactions (Monitor Closely): - Probenecid: can increase nitrofurantoin plasma levels. - Ciprofloxacin: additive risk of tendonitis. - Diabetes medications: may affect glucose control, requiring monitoring.